CDK4 and colorectal carcinoma: RA treatment in CRC cells inhibited proliferation-induced cell cycle arrest of the G0/G1 phase by reducing the cyclin D1 and CDK4 levels, inhibiting cyclin D1 and CDK4 mRNA expression [79].